top of page
Life Sciences Investors React To First 10 Drugs Selected For Government Price Controls
Executive Director John Stanford issued a statement in response. WASHINGTON, D.C. (August 29,2023) — Today, the Centers for Medicare &...
Incubate Coalition
Aug 28, 2023
Incubate Submits Comment In Response To Draft Legislation To Reauthorize PAHPA
Incubate recently submitted comment in response to the Senate HELP Committee’s draft legislation to reauthorize the Pandemic and...
Incubate Coalition
Jul 9, 2023
Massachusetts Biotech Community Calls On Congress To Fix The Small Molecule Penalty
Given the tremendous focus of MA-based companies and investors, we had an opportunity to pen some thoughts which are shared in the...
Incubate Coalition
May 21, 2023
Incubate Submits Comment To CMS Regarding Its Draft Guidance For The Medicare Drug Price Negotiation Program
Incubate submitted our feedback to the Centers for Medicare & Medicaid Services regarding its draft guidance for the Medicare Drug Price...
Incubate Coalition
Apr 16, 2023
Incubate Testifies At USITC Hearing
Executive Director John Stanford testified before the International Trade Organization.
Incubate Coalition
Mar 30, 2023
bottom of page